FULCRUM THERAPEUTICS, INC.: cashflow_investing
| Value | {"amount": -57138000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2020-01-01 – 2020-12-31 |
| Status | current |
| Entity | FULCRUM THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:14:49.682804+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/1c856b02-ed19-45d0-b48e-2c8354bf6b6e
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-21-010715 · Open the official SEC filing →Retrieved: 2026-08-19T17:14:49.682804+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001680581/cashflow-investing/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/1c856b02-ed19-45d0-b48e-2c8354bf6b6e
History
- no predecessors — first report